Skip to main content
. Author manuscript; available in PMC: 2022 Aug 23.
Published in final edited form as: J Clin Lipidol. 2012 Apr 13;6(3):216–234. doi: 10.1016/j.jacl.2012.04.077

Table 1.

Proportional hazard ratios for fatty acids in serum cholesteryl esters in relation to CVD and total mortality

Fatty acid and estimated desaturase activities Scrum proportion* Cardiovascular disease mortality (n = 461 events) Total mortality (n = 1012 events)
Crude Adjusted Crude Adjusted
% of total FAs
Myristic acid (14:0) 1.1 ± 0.3 1.16 (1.06, 1.27) 1.12 (1.02, 1.23) 1.09 (1.03, 1.16) 1.06 (0.99, 1.13)
Palmitic acid (16:0) 11.7 ± 0.99 1.25 (1.14, 1.37) 1.15 (1.04, 1.26) 1.16 (1.09, 1.24) 1.09 (1.02, 1.17)
Palmitoleic acid (16:1) 3.5 (3.0–4.4) 1.32 (1.21, 1.44) 1.18 (1.07, 1.30) 1.28 (1.21, 1.36) 1.19 (1.11, 1.27)
Stearic acid (18:0) 1.1 (0.97–1.3) 1.07 (0.97, 1.17) 1.04 (0.94, 1.15) 1.01 (0.95, 1.08) 0.98 (0.91, 1.04)
Oleic acid (18:1) 19.4 ± 2.7 1.29 (1.18, 1.41) 1.18 (1.07, 1.30) 1.25 (1.18, 1 33) 1.17 (1.10, 1.25)
Linoleic acid (18:2n–6) 53.9 ± 5.2 0.76 (0.70, 0.83) 0.85 (0.78, 0.94) 0.80 (0.76, 0.85) 0.87 (0.81, 0.93)
γ-Linolenic acid (18:3n–6) 0.71 ± 0.30 1.15 (1.05, 1.27) 1.09 (0.98, 1.21) 1.08 (1.01, 1.15) 1.04 (0.97, 1.11)
α-Linolenic acid (18:3n–3) 0.66 ± 0.16 1.08 (0.99, 1.18) 1.10 (1.0, 1.21) 1.03 (0.97, 1.09) 1.03 (0.97, 1.10)
Dihomo-γ-linolenic acid (20:3n–6) 0.57 ± 0.13 1.16 (1.07, 1.27) 1.06 (0.96, 1.18) 1.07 (1.01, 1.14) 1.0 (0.94, 1.08)
Arachidonic acid (20:4n–6) 4.8 ± 0.93 1.00 (0.92, 1.10) 0.95 (0.86, 1.05) 0.98 (0.92, 1.04) 0.96 (0.90, 1.02)
Eicosapentaenoic acid (20:5n–3) 1.3 (0.9–1.6) 1.07 (0.98, 1.17) 0.99 (0.90, 1.09) 1.04 (0.98, 1.11) 1.0 (0.94, 1.08)
Docosahexaenoic acid (22:6n–3) 0.68 (0.56–0.81) 0.97 (0.89, 1.07) 0.92 (0.84, 1.02) 0.96 (0.90, 1.02) 0.95 (0.89, 1.02)
SCD (16:1/16:0) 0.30 (0.26–0.37) 1.27 (1.16, 1.39) 1.15 (1.04, 1.27) 1.26 (1.18, 1.34) 1.18 (1.10, 1.26)
D6D (18:3n–6 /18:2n–6) 0.012 (0.009–0.017) 1.20 (1.10, 1.32) 1.12 (1.0, 1.24) 1.12 (1.06, 1.19) 1.07 (1.0, 1.14)
D5D (20:4n–6/20:3n–6) 8.6 ± 2.0 0.84 (0.76, 0.93) 0.88 (0.80, 0.98) 0.92 (0.86, 0.98) 0.96 (0.89, 1.02)

CVD, cardiovascular disease; FAs, fatty acids; SCD, steroyl-CoA-desaturated; D6D, Δ6-desaturase; D5D, Δ5-desaturase.

*

Values are means ± SD or means (interquartile ranges).

Values are hazard ratios (95% confidence intervals).

The adjusted model included total-C, body mass index, smoking, physical activity, and hypertension.

Permission to reuse table granted by American Society for Nutrition.39